Wound Care Prior Authorization Guide: Skin Substitutes, NPWT, and HBOT

Wound Care Prior Authorization Guide

Prior authorization is one of the biggest operational bottlenecks in wound care. Wound care sits at the intersection of high-cost products, payer-specific rules, and LCD-driven clinical documentation. A PA submission missing one clinical element -- wound size progression, conservative therapy timeline, or medical necessity language -- gets denied, and the treatment sits on hold while your patient's wound deteriorates.

This guide covers which treatments require PA, the workflow that prevents stalls, the documentation that gets approvals, and what to do when the payer says no.

Which Wound Care Treatments Require Prior Auth?

The answer depends entirely on the payer. There is no universal PA requirement for wound care -- the rules vary by payer type, plan, and treatment category. Here's how it breaks down.

Medicare Fee-for-Service (Generally No PA)

Traditional Medicare (Parts A and B) generally does not require prior authorization for wound care procedures. Debridement, E/M visits, NPWT, and most wound care services are covered when they meet LCD criteria -- no PA needed.

As of 2026, skin substitutes and NPWT are not part of the mandatory Medicare FFS prior authorization program. CMS can add categories at any time, so monitor the CMS Prior Authorization page for updates.

The catch: no PA doesn't mean no documentation requirements. Medicare FFS reviews claims post-payment against LCD criteria. A claim that passes without PA can still be denied on post-payment review. The documentation bar is the same -- you just find out later if you missed it.

Medicare Advantage Plans (Almost Always PA)

Medicare Advantage is where prior authorization dominates wound care. MA plans are private insurers administering Medicare benefits, and most of them layer PA requirements on top of Medicare coverage criteria.

Skin substitutes and CTPs -- nearly always require PA from MA plans. The payer wants to see wound chronicity, failed conservative therapy, wound measurements, and clinical photos before approving a graft application. Some MA plans require PA for each application in a series, not just the first one.

NPWT (Negative Pressure Wound Therapy) -- PA required by most MA plans. The typical requirement is documented wound size, wound type qualifying for NPWT (usually Stage III/IV pressure injuries, dehisced surgical wounds, or chronic wounds with adequate debridement), and evidence that the wound hasn't responded to standard moist wound therapy.

HBOT (Hyperbaric Oxygen Therapy) -- PA required by essentially every payer, including MA plans. HBOT is high-cost, and payers want extensive documentation of qualifying diagnosis (typically Wagner Grade III+ diabetic foot ulcers), failed standard wound care of 30+ days, and adequate vascular status.

Commercial Payers (Varies by Contract)

Commercial payers set their own PA requirements, and they vary widely. Some mirror Medicare criteria. Others have proprietary medical policies that are more restrictive.

The only reliable approach: verify PA requirements for every patient and every treatment, every time. Don't assume that because a payer didn't require PA last quarter, they won't require it now -- commercial payers update their PA lists regularly.

The Prior Authorization Workflow

A PA workflow that works at scale has five steps. Skip any of them and you create delays that cost you treatment time and revenue.

Step 1: Check Eligibility and PA Requirements

Before scheduling an advanced wound care treatment, verify two things: (1) the patient's coverage is active, and (2) the specific treatment requires PA under their plan.

For Medicare Advantage, check the payer's provider portal or call the number on the card. For commercial payers, use the portal or the 270/271 eligibility transaction. Document what you find -- "PA not required" is as important to record as "PA required, reference number pending."

Step 2: Gather Clinical Documentation

PA submissions live or die on clinical documentation. Before you submit, assemble:

Wound measurements from at least the last 4 weeks showing size progression (or lack of healing that justifies escalation)
Conservative therapy documentation -- what was tried, for how long, and why it didn't work
Clinical photographs showing wound bed condition, periwound skin, and any relevant clinical features
Medical necessity narrative -- a clear, LCD-aligned statement of why this treatment is needed for this wound at this time
Patient history relevant to wound healing -- diabetes status, vascular studies, nutritional status, offloading compliance

Step 3: Submit the Request

Submit through the payer's required channel -- portal, fax, or phone. Include every supporting document in the initial submission. Incomplete submissions get pended, not reviewed, and "pended" means your timeline just doubled.

Record the submission date, the payer's reference number, and the expected turnaround time.

Step 4: Track Status and Follow Up

PA requests don't track themselves. Set a follow-up cadence:

Day 3-5 after submission: verify the payer received and accepted the request (not pended for missing info)
Day 10-12: if no decision, call for status. Document who you spoke to and what they said
Day 14+: escalate. If the payer is past their stated turnaround and the patient's clinical situation is time-sensitive, request an expedited review

Step 5: Handle the Decision

Approved: document the authorization number, effective dates, and any limitations (number of applications, specific products, duration). Bill with the auth number on every claim
Denied: don't stop. Move to the appeal process (see below)
Partially approved: common with skin substitutes -- payer approves 3 applications when you requested 6. Document the limitation and plan re-authorization before the approved applications run out

Documentation That Gets Prior Auths Approved

The clinical documentation that gets PAs approved is the same documentation that keeps claims clean on the back end. There's no separate "PA documentation" standard -- it's LCD-compliant charting applied at the point of authorization.

Wound Measurements with Size Progression

Payers want to see that the wound isn't healing under current therapy. That means serial measurements -- length, width, and depth in centimeters -- over at least 4 weeks. A wound that went from 4.2 x 3.1 cm to 4.0 x 3.0 cm in 30 days hasn't meaningfully progressed. That's your clinical justification for escalation.

Failed Conservative Therapy (The "4-Week Rule")

Most payers and LCDs require documentation that the wound has not responded to at least 30 days of standard wound care before approving advanced therapies. "Standard wound care" means appropriate debridement, moist wound therapy, offloading (for lower extremity wounds), infection management, and nutritional optimization.

Document what you did, when you started it, and what happened. "Patient received standard wound care" is not sufficient. "Patient received weekly sharp debridement, collagen dressing changes every 3 days, and offloading with a DH walker from 3/1 through 3/31 with wound area decreasing from 8.4 sq cm to 7.9 sq cm (6% reduction, below the 40-50% threshold for expected healing)" is sufficient.

Clinical Photos

Photos should show the wound bed, wound margins, and a ruler or measurement reference in the frame. Date-stamped and linked to the patient chart. Include them with every submission regardless of whether the payer explicitly requires them -- they strengthen every request.

Medical Necessity Language

Write the narrative in LCD-aligned language. Reference the specific LCD criteria the wound meets. Name the diagnosis, the wound classification, the failed therapies, and the clinical rationale for the requested treatment. Avoid vague language like "wound is not healing well" -- quantify everything.

Timeline Management

PA timelines vary by payer type and urgency:

Standard PA turnaround:

Medicare Advantage: 7-14 calendar days (CMS requires MA plans to decide within 14 days for standard requests)
Commercial payers: 5-15 business days, varies by contract
Medicaid managed care: 3-14 calendar days, varies by state

Urgent/expedited PA:

CMS requires MA plans to decide within 72 hours for expedited requests where standard timing could jeopardize the patient's health
Commercial payers may offer expedited review -- ask

When PA takes too long:

If an MA plan hasn't decided within 14 days, the request is deemed approved under CMS rules. Document the submission date and the lack of response, then proceed with treatment and bill with a note referencing the deemed approval
For commercial payers, there's no universal deemed-approval rule, but many states have prompt-decision laws. Know your state's requirements
If the delay is clinically dangerous, document the urgency, request expedited review, and escalate to the payer's medical director

When Prior Auth Is Denied: The Appeal Playbook

A PA denial is not a final answer. It's the start of a structured appeal process, and the practices that work their denials recover a significant percentage of them.

Peer-to-Peer Review

Most payers offer a peer-to-peer review where the treating clinician speaks directly with the payer's medical director. This is your highest-value appeal step. The clinician who examined the wound explains to another clinician why the treatment is necessary. Come prepared with measurements, photos, treatment history, and the specific LCD criteria the wound meets. A well-prepared peer-to-peer reverses a significant share of denials.

Written Appeal with Clinical Evidence

If peer-to-peer doesn't resolve it, submit a formal written appeal. Include everything from the original submission plus the denial reason and why it's incorrect, additional clinical evidence gathered since submission, peer-reviewed literature supporting the treatment, and a point-by-point rebuttal of the denial rationale.

Reference the specific LCD or payer medical policy criteria and show how the patient meets each one. Make the reviewer's job easy -- don't make them hunt for the clinical justification.

External Review

If internal appeals are exhausted, patients (and in some states, providers) can request an Independent Review Organization (IRO) external review. This is a third-party clinical review that's binding on the payer. Worth pursuing for high-value treatments like skin substitute series or HBOT courses where the total claim value justifies the effort.

For a broader look at managing the full denial lifecycle -- from root cause analysis through appeal execution -- see the denial management guide and the denial rate reduction guide.

Common PA Pitfalls

These are the five scenarios where prior authorization fails most often in wound care practices -- and how to prevent each one.

1. Submitting without the 4-week conservative therapy window. The clinician knows the wound needs a graft, but the chart only shows 2 weeks of conservative therapy documentation. The PA gets denied for insufficient trial of standard care. Prevention: track the conservative therapy start date per wound and flag when the 4-week threshold is approaching.

2. Letting the authorization expire before completing treatment. Skin substitute PAs are often time-limited -- 90 days, or a specific number of applications. If treatment extends beyond the authorization window, the remaining applications are unbillable. Prevention: calendar the expiration date and submit re-authorization 2-3 weeks before it hits.

3. Applying the wrong product. The PA approved Product A, but the clinician applied Product B because it was what was available in the wound care kit that day. The claim gets denied for product mismatch. Prevention: match PA approval to inventory on hand before the visit, not during.

4. Missing the appeal window. Most payers give 60-180 days to appeal a PA denial. If the denial sits in a fax folder for 45 days before someone reviews it, the appeal window may be too tight to mount a proper response. Prevention: route denials to a queue with SLA tracking -- every denial gets reviewed within 5 business days.

5. Not verifying PA requirements changed. A payer that didn't require PA for NPWT last year now does. The practice applies NPWT without PA, bills the claim, and gets denied. Prevention: re-verify PA requirements at the point of eligibility check, every time, for every patient. Practices that track PA status per wound alongside clinical documentation catch these changes before they become denials -- Medipyxis links PA tracking to the wound record so nothing falls through the gap between authorization and billing.

Prior Auth Is a Clinical Workflow Problem, Not a Billing Problem

The practices that manage prior authorization well don't treat it as an administrative task that happens after the clinical decision. They build PA awareness into the clinical workflow: checking requirements at eligibility verification, gathering documentation as part of routine wound charting, submitting requests before scheduling advanced treatments, and tracking authorization status alongside wound healing progress.

When PA is an afterthought, it delays care. When it's built into the workflow, it becomes invisible -- the documentation that supports the PA is the same documentation that supports the claim, and the tracking that prevents PA expiration is the same tracking that prevents billing denials.

The wound doesn't wait for the payer to decide. Build the process so the decision is already made before the wound needs it.

Want the complete operational playbook? Download The Mobile Wound Care Playbook -- includes PA workflows, billing SOPs, compliance frameworks, and revenue cycle strategy for wound care practices.